So much has been written about protein for endurance athletes that the topic feels closed: 1.6–2.0 g per kg of body mass, spread across meals, don't forget the post-workout serving. But inside protein there is one amino acid that works less like building material and more like a signal — and the research around it keeps getting more interesting. A recent study produced an unexpectedly concrete result.

How leucine differs from «just protein»

Leucine is one of the three branched-chain amino acids (BCAAs), alongside valine and isoleucine. What makes it special is that the body uses it not only as raw material for muscle protein synthesis, but as a trigger: leucine activates the mTOR signalling pathway, which starts the synthesis process itself. Crudely: the other amino acids are bricks, while leucine also gives the order to start building.

Hence the idea that what matters is not only total protein but whether a given meal clears the «leucine threshold» — the dose sufficient to fire the signal. In strength sports this logic has been working for a long time. In endurance it has been tested less often, which is what makes this interesting.

There is a second line of reasoning, much closer to endurance. BCAAs compete with tryptophan for the same transporter across the blood-brain barrier. Tryptophan is a precursor of serotonin, and rising brain serotonin during prolonged work is linked to central fatigue: the feeling that your legs could still go but the desire to continue has left. In theory, elevated BCAA levels should suppress that transport. The theory is elegant; its relationship with practice has historically been complicated.

What the study found

The work was published in Metabolites in January 2026. The design is a randomised controlled trial with targeted metabolomics.

Participants were 20 cross-country skiers split into two groups. The experimental group received 8.5 g of leucine plus 14 g of sucrose, the control group only 14 g of sucrose. Intake was twice daily, Monday through Saturday, for six weeks. An important design detail: both groups received the sucrose, so carbohydrate is excluded as a variable — leucine itself is what is being compared.

Body composition, aerobic capacity, isokinetic strength, blood biochemistry and metabolomics were all measured.

Results versus placebo:

VO₂max — higher (p = 0.01);
ankle muscle strength on the isokinetic test — higher (p = 0.01);
serum valine — higher (p = 0.03).

Metabolomics showed that the differential metabolites clustered in branched-chain amino acid biosynthesis and degradation pathways. The supplement did not simply pass through — it shifted metabolism exactly where you would expect.

What deserves caution here

Twenty people is few. Split into two groups and you have ten in each. At that sample size an individual result at p = 0.01 looks convincing, but the stability of the whole picture will have to be confirmed by other work.

Next: the strength gain was measured at the ankle. This is not abstract «leg strength» — it is an isokinetic test of one specific joint. The ankle matters for a skier, and for a runner too, but you cannot extrapolate this to «got stronger» in any broad sense.

Third: the participants were cross-country skiers in training. Six weeks of training moves VO₂max on its own, so the finding concerns a gain on top of what training would deliver — but how large that gain is in absolute numbers does not follow from the available description. The cautious phrasing: the direction is there, the effect size needs clarifying.

One more thing about what is not in the results. Central fatigue appears in the study's title, but the summary reports no specific figures for it. So I would not yet connect this result to the «BCAAs versus serotonin» hypothesis — those are different levels of evidence.

How to apply this

The practical conclusion is more modest than one would like, but it exists.

Cover total protein first. If you eat 1.2 g/kg, a leucine supplement is not the lever to pull. Leucine works on top of adequate protein, not instead of it. The calculator below will help estimate your calorie and protein needs.
Look at servings, not daily totals. Roughly 25–30 g of quality animal protein contains about 2–3 g of leucine. That is the threshold the recommendations are built around. If your protein is smeared across the day in small doses, the problem is distribution, not supplementation.
The study dose is high. 8.5 g twice daily is 17 g of leucine per day, substantially more than you get from a normal diet. This is a research protocol, not an everyday recommendation.
Do not confuse leucine with a BCAA blend. BCAA mixtures have a decidedly mixed record in endurance sport, and isolated amino acids do not replace complete protein.

Who might find this most relevant: anyone constrained in total protein for some reason — on a plant-based diet, where the leucine density of sources is lower, or during a calorie deficit.

Key points

Leucine is not merely building material but a signal for muscle protein synthesis via the mTOR pathway.
In the 2026 study, 20 cross-country skiers took 8.5 g of leucine twice daily for six weeks; both groups received identical sucrose.
Versus placebo, VO₂max (p = 0.01), isokinetic ankle strength (p = 0.01) and serum valine (p = 0.03) all increased.
Metabolomics confirmed a shift in branched-chain amino acid metabolism pathways.
The limitations are substantial: only 20 participants, strength measured at a single joint, effect size in absolute terms unclear.
This work neither confirms nor refutes the central fatigue hypothesis — no data on it appear in the available summary.
Practice: total protein of 1.6–2.0 g/kg and sensible distribution across meals first; only then a conversation about individual amino acids.

Sources: «Effects of Leucine Supplementation on Athletic Performance, Central Fatigue, and Serum Metabolism in Endurance Athletes: A Randomized Controlled Trial and Targeted Metabolomics Study», Metabolites, 2026;16(2):94. https://doi.org/10.3390/metabo16020094